We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are going to take a look at where Iron Mountain Incorporated (NYSE:IRM) stands against the other AI ...

The Toronto Blue Jays are determined to being the bride and not the bridesmaid, and are already considering Anthony Santander as a free agent option ...

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Virginia G. Kaklamani, MD, DSc, discusses findings from the phase 3 TROPION-Breast01 trial of datopotamab deruxtecan.

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.

As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...

Chris Dzadovsky applied for Fort Pierce city manager job, but didn't see his name on lists presented to city commissioners.

Actively encouraging proficiency will also elevate your employee value proposition. There is more AI coming. Employees who ...

Artificial intelligence and job-hopping employees are front-and-center issues for business owners and managers.

Companies can close the gap by upskilling and reskilling, according to LinkedIn’s head of global talent acquisition.

Cognizant’s new Neuro AI Multi-Agent Accelerator aims to tie AI agents from multiple disparate applications into scalable ...